uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
RAS mutations in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC).
Show others and affiliations
2014 (English)In: Journal of Clinical Oncology, ISSN 0732-183X, E-ISSN 1527-7755, Vol. 32, no 3Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 32, no 3
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-224776ISI: 000333682100481OAI: oai:DiVA.org:uu-224776DiVA: diva2:718806
Gastrointestinal Cancers Symposium, JAN 16-18, 2014, San Francisco, CA
Available from: 2014-05-22 Created: 2014-05-20 Last updated: 2014-05-22Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Glimelius, Bengt
By organisation
In the same journal
Journal of Clinical Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 174 hits
ReferencesLink to record
Permanent link

Direct link